ストックスクリーナーアプリを入手
12.00
3.27%
0.38
アフターアワーズ：
11.95
-0.05
-0.42%
前日終値:
$11.62
開ける：
$11.63
24時間の取引高:
1.14M
Relative Volume:
1.03
時価総額：
$1.17B
収益：
-
当期純損益:
$-137.25M
株価収益率:
-6.3492
EPS:
-1.89
ネットキャッシュフロー:
$-121.97M
1週間 パフォーマンス:
+14.50%
1か月 パフォーマンス:
+17.30%
6か月 パフォーマンス:
+115.05%
1年 パフォーマンス:
+17.07%
1日の値動き範囲:
$11.50
$12.05
1週間の範囲:
$10.11
$12.05
52週間の値動き範囲:
$3.8951
$14.67
Oric Pharmaceuticals Inc Stock (ORIC) Company Profile
名前
Oric Pharmaceuticals Inc
セクター
電話
(650) 388-5600
住所
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
ORIC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ORIC
Oric Pharmaceuticals Inc
|
12.00 | 1.13B | 0 | -137.25M | -121.97M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-04 | 再開されました | Guggenheim | Buy |
| 2025-07-08 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-10-31 | 開始されました | Wells Fargo | Overweight |
| 2024-09-06 | 開始されました | Stifel | Buy |
| 2024-02-23 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-09-22 | 開始されました | Wedbush | Outperform |
| 2023-03-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-03-21 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-16 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-07-18 | 再開されました | Oppenheimer | Perform |
| 2022-04-04 | アップグレード | Citigroup | Neutral → Buy |
| 2022-03-25 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2022-03-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-03-22 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-03-22 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2021-07-06 | アップグレード | Citigroup | Neutral → Buy |
| 2021-01-25 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-08-13 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-06 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-03 | 開始されました | H.C. Wainwright | Buy |
| 2020-05-19 | 開始されました | Citigroup | Neutral |
| 2020-05-19 | 開始されました | Guggenheim | Buy |
| 2020-05-19 | 開始されました | JP Morgan | Overweight |
| 2020-05-19 | 開始されました | Jefferies | Buy |
すべてを表示
Oric Pharmaceuticals Inc (ORIC) 最新ニュース
Will ORIC Pharmaceuticals Inc. stock attract ESG investors2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Is ORIC Pharmaceuticals Inc. stock poised for growthPortfolio Value Summary & AI Forecasted Entry and Exit Points - newser.com
How higher bond yields impact ORIC Pharmaceuticals Inc. (4TZ) stock2025 EndofYear Setup & AI Enhanced Execution Alerts - newser.com
ORIC Pharmaceuticals Inc 4TZ Stock Analysis and ForecastMarket Correction Analysis & Expert-Backed Recommendations That Deliver - earlytimes.in
Published on: 2025-09-29 09:52:14 - newser.com
Candlestick signals on ORIC Pharmaceuticals Inc. stock todayRisk Management & Consistent Profit Alerts - newser.com
Identifying reversal signals in ORIC Pharmaceuticals Inc.July 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
Top chart patterns to watch in ORIC Pharmaceuticals Inc.Trade Performance Summary & Growth Focused Entry Point Reports - newser.com
ORIC Pharmaceuticals Inc Stock Analysis and ForecastLow Risk Investment Ideas & Learn the Secrets of Pro Traders - Early Times
Merus NV and ORIC Pharmaceuticals Inc at Citi BioPharma Conferen - GuruFocus
How robust is ORIC Pharmaceuticals Inc. (4TZ) stock financial positionMarket Sentiment Summary & Breakout Confirmation Trade Signals - newser.com
Cantor Fitzgerald reiterates Overweight rating on ORIC Pharmaceuticals stock By Investing.com - Investing.com Canada
Palumbo Wealth Management LLC Takes Position in Oric Pharmaceuticals, Inc. $ORIC - MarketBeat
Oric Pharmaceuticals (NASDAQ:ORIC) CEO Sells $1,350,000.00 in Stock - MarketBeat
Rhumbline Advisers Decreases Stock Position in Oric Pharmaceuticals, Inc. $ORIC - Defense World
Should you hold or exit ORIC Pharmaceuticals Inc. now2025 Year in Review & Daily Profit Maximizing Tips - newser.com
Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $17.29 Average PT from Analysts - MarketBeat
Real time scanner hits for ORIC Pharmaceuticals Inc. explainedTrade Risk Assessment & Expert Approved Momentum Trade Ideas - newser.com
How to use a screener to detect ORIC Pharmaceuticals Inc. breakoutsTake Profit & Verified Momentum Stock Ideas - newser.com
Stock Recap: What are ORIC Pharmaceuticals Incs recent SEC filings showingWeekly Investment Report & Advanced Swing Trade Entry Alerts - خودرو بانک
Is ORIC Pharmaceuticals Inc. trending in predictive chart modelsJuly 2025 News Drivers & Weekly Breakout Opportunity Watchlist - newser.com
US Stocks Recap: Does ORIC Pharmaceuticals Inc. align with a passive investing strategyJuly 2025 Breakouts & Verified Momentum Watchlists - خودرو بانک
Will ORIC Pharmaceuticals Inc. outperform the marketShort Setup & Weekly Market Pulse Updates - newser.com
Risk Check: What’s ORIC Pharmaceuticals Inc.’s historical return2025 Sector Review & Smart Money Movement Tracker - خودرو بانک
How institutional ownership impacts ORIC Pharmaceuticals Inc. stockJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
How to recover losses in ORIC Pharmaceuticals Inc. stockEarnings Risk Report & Safe Entry Zone Identification - newser.com
Quarterly Risk: Will ORIC Pharmaceuticals Inc benefit from current market trendsLayoff News & Safe Entry Point Identification - خودرو بانک
Published on: 2025-09-18 21:52:52 - newser.com
Aug Wrap: Is ORIC Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Reactions & Real-Time Chart Pattern Alerts - خودرو بانک
Oric Pharmaceuticals Inc (ORIC) 財務データ
収益
当期純利益
現金流量
EPS
2.36%
1.10%
大文字化:
|
ボリューム (24 時間):